Renovize Pharma LLP
About Renovize Pharma LLP
Data last updated:
Renovize Pharma LLP is a limited liability partnership (LLP) based in Kolkata, West Bengal, India. It operates in the chemical distribution and retail segment of the chemicals and materials sector. It was incorporated on 19 March 2019 and has been in existence for over 7 years.
The LLP is registered with the Registrar of Companies (ROC), Kolkata, under LLPIN AAO-5879. Its GSTIN is 26AAZFR4265K1ZC (Dadra and Nagar Haveli and Daman and Diu).
The LLP has a total obligation of contribution of ₹2 Lakh. It is led by designated partners Madhur Kanodia and Abhay Basant Kejriwal.
Its latest statement of accounts is for the year ended 31 March 2024. The registered office is at 180 S. P. Mukherjee Road, Kolkata, West Bengal, India – 700026.
As per the financials filed for FY 2021, the LLP reported a revenue of ₹82.01 Lakh. For the same year it recorded a net profit of ₹65,582 (net margin 0.8%) and EBITDA of -₹3.48 Lakh (EBITDA margin -4.2%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address180 S. P. Mukherjee Road, Kolkata, West Bengal, India – 700026
- IndustryChemicals and Materials, Chemical Distribution & Retail
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Renovize Pharma LLP FY 2024 filings available
Renovize Pharma LLP reported revenue of ₹82.01 Lakh for FY 2021.
Financial Statement Summary of Renovize Pharma LLP
| Statement of Account and Solvency | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|
| Income and Expenditure | |||
| Turnover | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• |
| Profit After Tax | ₹65,582 | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• |
| Assets and Liabilities | |||
| Partners' Contribution | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Renovize Pharma LLP
| Statement of Account and Solvency | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|
| Profitability | |||
| Net Profit Margin | 0.8% | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Renovize Pharma are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Renovize Pharma LLP
Renovize Pharma has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhur Kanodia | Designated Partner | 19 Mar 2019 | 7 Years 6 Months | Current |
| Abhay Basant Kejriwal Also directs: Vitamediq Life Science Private Limited, Merit Polychem Pvt. Ltd. | Designated Partner | 19 Mar 2019 | 7 Years 6 Months | Current |
Ownership and Shareholding of Renovize Pharma LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Renovize Pharma LLP
Renovize Pharma LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Renovize Pharma LLP
Employment history and EPFO contributions of people linked to Renovize Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Renovize Pharma LLP
Renovize Pharma LLP has 2 designated partner changes on record since 2019: 2 appointments. The latest: Abhay Basant Kejriwal was appointed as Designated Partner on 19 Mar 2019.
Credit Ratings, Litigation & Regulatory Alerts for Renovize Pharma LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Renovize Pharma LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Renovize Pharma LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Renovize Pharma LLP
Renovize Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 26AAZFR4265K1ZC | Dadra and Nagar Haveli and Daman and Diu | Active | 01 Sep 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Renovize Pharma LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Renovize Pharma LLP
Renovize Pharma is an active limited liability partnership based in Kolkata, West Bengal, India. The LLP works in chemical distribution and retail, within the chemicals and materials industry. It was incorporated on 19 March 2019 (7+ years old) and is registered under LLPIN AAO-5879.
Renovize Pharma reported revenue of ₹82.01 Lakh for FY 2021.
Renovize Pharma has 2 current designated partners:
- Madhur Kanodia - Designated Partner
- Abhay Basant Kejriwal - Designated Partner
Renovize Pharma reported a net profit of ₹65,582 (net margin 0.8%) and EBITDA of -₹3.48 Lakh (EBITDA margin -4.2%) for FY 2021, as per its filed financial statements.
The GSTIN of Renovize Pharma is 26AAZFR4265K1ZC, registered in Dadra and Nagar Haveli and Daman and Diu.
The LLPIN (Limited Liability Partnership Identification Number) of Renovize Pharma is AAO-5879. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Renovize Pharma was incorporated on 19 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Kolkata.
Abhay Basant Kejriwal was appointed as Designated Partner on 19 Mar 2019. Madhur Kanodia was appointed as Designated Partner on 19 Mar 2019.
The registered office of Renovize Pharma is at 180 S. P. Mukherjee Road, Kolkata, West Bengal, India – 700026.
The total obligation of contribution is ₹2 Lakh.